Real-time enrollment status for this immune-mediated colitis (imc) clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 5:34 AM UTC
| NCT Number | NCT06499896 |
| Recruiting Status | Recruiting |
| Condition | Immune-mediated Colitis (IMC) |
| Phase | PHASE2 |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Diwakar Davar |
| Last Updated on CT.gov | February 9, 2026 (Feb 9, 2026) |
As of July 18, 2026: Clinical trial NCT06499896 is currently recruiting participants. This phase2 study for immune-mediated colitis (imc) is actively seeking new participants at 1 location across the United States. The study is sponsored by Diwakar Davar. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06499896 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06499896 was last updated Feb 9, 2026 (February 9, 2026). HelloStudys verifies this status automatically.